Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Works of Mor Moskovitz being referenced
A phase Ib, open-label, dose-escalation trial of naptumomab estafenatox (Nap) in combination with durvalumab (MEDI4736) in subjects with selected advanced or metastatic solid tumors.
2020
ALK-Rearranged Non–Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mor Moskovitz | 425 | 386 | 83 | 136 | 60 | 779 | |
| Andriani Charpidou | 299 | 267 | 68 | 119 | 66 | 661 | |
| Hong Jian | 373 | 347 | 123 | 288 | 48 | 940 | |
| Marion Sassier | 644 | 247 | 34 | 91 | 38 | 958 | |
| Polly Niravath | 446 | 205 | 220 | 190 | 52 | 938 | |
| Burhan Turgut | 206 | 126 | 25 | 123 | 63 | 859 | |
| Bo Li | 320 | 274 | 122 | 167 | 49 | 840 | |
| Eun Hyo Jin | 316 | 296 | 102 | 147 | 63 | 849 | |
| Dominique Genet | 416 | 226 | 88 | 91 | 41 | 876 | |
| Bin You | 101 | 256 | 79 | 229 | 55 | 801 | |
| Arash Mohammadi Tofigh | 274 | 121 | 249 | 59 | 34 | 764 |
All Works
Loading papers...